Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.10.2 (
focal adhesion kinase
)
44,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bruton's tyrosine kinase
(
Btk
) plays crucial roles in B cell differentiation as well as mast cell activation through the high-affinity
IgE
receptor (FcepsilonRI). Defects in the btk gene lead to agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (xid) in mice. Mast cells from xid and btk null mice exhibit mild defects in degranulation and severe impairments in the production of proinflammatory cytokines upon FcepsilonRI cross-linking. Recent studies demonstrated the role of
Btk
in a sustained increase in intracellular calcium concentrations in response to antigen receptor stimulation.
Btk
is also involved in the activation of stress-activated protein kinases, JNK/SAPK1/2, and thereby regulates c-Jun and other transcription factors that are important in cytokine gene activation. Regulation of the JNK/SAPK activation pathway by
Btk
may be related to the proapoptotic function of
Btk
in the programmed cell death in these hematopoietic cells.
...
PMID:Functions of Bruton's tyrosine kinase in mast and B cells. 1008 May 29
We investigated the role of
JAK3
in
IgE
receptor/FcepsilonRI-mediated mast cell responses.
IgE
/antigen induced degranulation and mediator release were substantially reduced with Jak3-/- mast cells from
JAK3
-null mice that were generated by targeted disruption of Jak3 gene in embryonic stem cells. Further, treatment of mast cells with 3'bromo-4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P154), a potent inhibitor of
JAK3
, inhibited degranulation and proinflammatory mediator release after
IgE
receptor/ FcepsilonRI crosslinking. Thus,
JAK3
plays a pivotal role in
IgE
receptor/ FcepsilonRI-mediated mast cell responses and targeting
JAK3
may provide the basis for new and effective treatment as well as prevention programs for mast cell-mediated allergic reactions.
...
PMID:Genetic and biochemical evidence for a critical role of Janus kinase (JAK)-3 in mast cell-mediated type I hypersensitivity reactions. 1020 64
A fraction of
Bruton's tyrosine kinase
(
Btk
) co-localizes with actin fibers upon stimulation of mast cells via the high affinity
IgE
receptor (FcepsilonRI). In this study, a molecular basis of the
Btk
co-localization with actin fibers is presented.
Btk
and other Tec family tyrosine kinases have a pleckstrin homology (PH) domain at their N termini. The PH domain is a short peptide module frequently found in signal-transducing proteins and cytoskeletal proteins. Filamentous actin (F-actin) is shown to be a novel ligand for a subset of PH domains, including that of
Btk
. The actin-binding site was mapped to a 10-residue region of the N-terminal region of
Btk
. Basic residues in this short stretch are demonstrated to be involved in actin binding. Isolated PH domains induced actin filament bundle formation. Consistent with these observations,
Btk
binds F-actin in vitro and in vivo. Wild-type
Btk
protein is in part translocated to the cytoskeleton upon FcepsilonRI cross-linking, whereas
Btk
containing a mutated PH domain is not. Phosphatidylinositol 3,4, 5-trisphosphate-mediated membrane translocation of
Btk
was enhanced in cytochalasin D-pretreated, FcepsilonRI-stimulated mast cells. These data indicate that PH domain-mediated F-actin binding plays a role in
Btk
co-localization with actin filaments.
...
PMID:Pleckstrin homology domains interact with filamentous actin. 1039 17
The
ZAP70
/Syk family of protein tyrosine kinases plays an important role in Ag receptor signaling. Structural similarity of Syk and
ZAP70
suggests their functional overlap. Previously, it was observed that expression of either
ZAP70
or Syk reconstitutes Ag receptor signaling in Syk-negative B cells. However, in CD45-deficient T cells, Syk, but not
ZAP70
, restores T cell receptor-signaling pathway. To study the function of Syk,
ZAP70
, and CD45 in mast cells, a Syk/CD45 double-deficient variant of RBL-2H3 cells was characterized. After transfection, stable cell lines were isolated that expressed
ZAP70
, Syk, CD45,
ZAP70
plus CD45, and Syk plus CD45.
IgE
stimulation did not induce degranulation in parental double-deficient cells, nor in the cells expressing only CD45.
ZAP70
expression did not restore Fc epsilon RI signaling unless CD45 was coexpressed in the cells. However, Syk alone restored the
IgE
signal transduction pathway. The coexpression of CD45 with Syk had no significant effects on the responses to FcepsilonRI-aggregation. There was much better binding of Syk than
ZAP70
to the phosphorylated Fc epsilon RI gamma-ITAM. Furthermore, unlike Syk,
ZAP70
required CD45 to display receptor-induced increase in kinase activity. Therefore, in mast cells,
ZAP70
, but not Syk, requires CD45 for Ag receptor-induced signaling.
...
PMID:CD45 is essential for Fc epsilon RI signaling by ZAP70, but not Syk, in Syk-negative mast cells. 1045 87
Two case histories were presented to show some of the typical pathological features of patients afflicted with human T-cell lymphotrophic virus type 1 (HTLV-1) and HIV, which act synergistically and are predictive of a rapidly fatal outcome. AIDS progression is hastened by co-infection with HTLV-1, probably because HTLV-1 tax gene turns on T cells that harbor HIV. Thus, in persons infected with both HTLV-1 and HIV, HIV seems to proliferate more readily. Features of HTLV-1 carrier are immunoparesis, loss of immediate skin reactivity, loss of IgG anti-parasite antibodies, and reduced or absent
IgE
antibodies. The immunosuppression and its consequences are similar in both HTLV-1 and HIV infection. The only solution to the AIDS epidemic in the Caribbean, which is also a region endemic for HTLV-1, would be the introduction of an effective vaccine against retroviral agents, HTLV-1 and HIV.
Int J
STD
AIDS 1999 Jul
PMID:Role of HTLV-1 co-infection in the AIDS epidemic in the Caribbean: a cause for concern. 1072 53
Janus kinase 3
(
JAK3
), a member of the Janus family protein-tyrosine kinases, is expressed in mast cells, and its enzymatic activity is enhanced by
IgE
receptor/FcepsilonRI cross-linking. Selective inhibition of
JAK3
in mast cells with 4-(4'-hydroxylphenyl)-amino-6, 7-dimethoxyquinazoline) (WHI-P131) blocked the phospholipase C activation, calcium mobilization, and activation of microtubule-associated protein kinase after lgE receptor/FcepsilonRI cross-linking. Treatment of
IgE
-sensitized rodent as well as human mast cells with WHI-P131 effectively inhibited the activation-associated morphological changes, degranulation, and proinflammatory mediator release after specific antigen challenge without affecting the functional integrity of the distal secretory machinery. In vivo administration of the
JAK3
inhibitor WHI-P131 prevented mast cell degranulation and development of cutaneous as well as systemic fatal anaphylaxis in mice at nontoxic dose levels. Thus,
JAK3
plays a pivotal role in
IgE
receptor/FcepsilonRI-mediated mast cell responses, and targeting
JAK3
with a specific inhibitor, such as WHI-P131, may provide the basis for new and effective treatment as well as prevention programs for mast cell-mediated allergic reactions.
...
PMID:Targeting Janus kinase 3 in mast cells prevents immediate hypersensitivity reactions and anaphylaxis. 1048 Sep 16
Two protein-tyrosine kinases,
Bruton's tyrosine kinase
(
Btk
) and Syk, and members of the protein kinase C (PKC) subfamily of serine/threonine kinases play crucial roles in signal transduction through antigen receptors in B lymphocytes and high-affinity
IgE
receptors (FcepsilonRI) in mast cells. The present study provides genetic, biochemical, and pharmacological evidence that, on FcepsilonRI stimulation, Syk regulates
Btk
, and
Btk
selectively regulates the membrane translocation and enzymatic activity of PKCbetaI among the conventional PKC isoforms (alpha, betaI, and betaII) expressed in mast cells. Syk/
Btk
-mediated PKCbetaI regulation is involved in transcriptional activation of the IL-2 and tumor necrosis factor alpha genes through the JNK pathway induced by FcepsilonRI stimulation. Accordingly, FcepsilonRI-induced production of these cytokines is inhibited by specific inhibitors of
Btk
and Syk, as well as broad-specificity inhibitors of PKC and a selective inhibitor of PKCbeta. Specific regulation of PKCbetaI by
Btk
is consistent with the selective association of
Btk
with PKCbetaI. Components of this signaling pathway may represent an attractive set of potential targets of pharmaceutical interference for the treatment of allergic and other immunologic diseases.
...
PMID:Regulation of protein kinase CbetaI by two protein-tyrosine kinases, Btk and Syk. 1085 54
The authors investigated the effects of 2,4,6-trihydroxy-alpha-p-methoxyphenylacetophenone (compound D-58), a potent inhibitor of protein tyrosine kinases
SYK
and
Bruton's tyrosine kinase
(
BTK
), on
IgE
receptor/FcepsilonRI-triggered mast cell-mediated acute allergic responses in vitro and in vivo. Compound D-58 abrogated
IgE
receptor/FcepsilonRI-mediated
SYK
and
BTK
activation as well as calcium mobilization in mast cells. Mast-cell degranulation and leukotriene (LT) C(4) release was inhibited by compound D-58 in a concentration-dependent fashion. Notably, compound D-58 prevented the mast cell mediator-induced vascular hyperpermeability in an in vivo murine model of passive cutaneous anaphylaxis as measured by the prevention of extravasation of systemically administered Evans blue dye. The results uniquely indicate that compound D-58 has potent antiallergic properties. Therefore, further development of compound D-58 may provide the basis for new and effective treatment programs for severe allergic disorders.
...
PMID:2,4,6-Trihydroxy-alpha-p-methoxyphenylacetophenone (Compound D-58) is a potent inhibitor of allergic reactions. 1170 80
Recent data suggest that initiation of signal transduction via type 1 Fc epsilon receptor (Fc epsilon RI) and other immunoreceptors is spatially constrained to lipid rafts. In order to better understand the complexity and function of these structures, we prepared mAb against lipid rafts from the rat basophilic leukemia cell line, RBL-2H3, which is extensively used for analysis of Fc epsilon RI-mediated activation. One of the antibodies was found to recognize a novel glycosylphosphatidylinositol-anchored plasma membrane glycoprotein of 250 amino acids, designated
TEC
-21, containing a cysteine-rich domain homologous to those found in the urokinase plasminogen activator receptor/Ly-6/snake neurotoxin family.
TEC
-21 is abundant on the surface of RBL-2H3 cells (>10 (6) molecules/cell), but is absent in numerous rat tissues except for testes. Aggregation of
TEC
-21 on RBL-2H3 cells induced a rapid increase in tyrosine phosphorylation of several substrates including Syk kinase and LAT adaptor, calcium flux, and release of secretory components. Similar but more profound activation events were observed in cells activated via Fc epsilon RI. However, aggregation of
TEC
-21 did not induce changes in density of
IgE
-Fc epsilon RI complexes, tyrosine phosphorylation of Fc epsilon RI beta and gamma subunits, and co-aggregation of Lyn kinase.
TEC
-21-induced activation events were also observed in Fc epsilon RI(-) mutants of RBL-2H3 cells. Thus,
TEC
-21 is a novel lipid raft component of RBL-2H3 cells whose aggregation induces activation independently of Fc epsilon RI.
...
PMID:A novel lipid raft-associated glycoprotein, TEC-21, activates rat basophilic leukemia cells independently of the type 1 Fc epsilon receptor. 1180 40
The molecular basis of common variable immunodeficiency (CVID) is unknown. To assess humoral immunity in CVID, we selected 24 patients with early or late onset of disease. X-linked agammaglobulinemia (XLA), X-linked hyper-IgM syndrome (XHIM), and non-XHIM were excluded based on clinical phenotype, assessment of the immune response, presence of
Bruton's tyrosine kinase
(
Btk
) in monocytes or platelets, and normal expression of CD40 ligand by activated T cells. The number of circulating B cells was within the normal range or reduced. IgD(-) CD27(+) memory B cells were markedly reduced or absent in all 24 patients and IgD(+) CD27(+) B cells were diminished in 8 patients. Circulating B cells from all 6 patients examined, including CVID patients with IgD(+) CD27(+) cells, failed to undergo somatic hypermutation in immunoglobulin-variable (V)-region genes, similar to cord blood B cells. B cells from CVID patients produced IgM and IgG, but not IgA upon the engagement of Ig receptor and CD40 in the presence of IL-2 and IL-10. B cells from all but 5 patients secreted
IgE
when stimulated by CD40 crosslinking in the presence of IL-4. The observation of defective memory B cells with abnormal cell marker expression and function demonstrates that naive CVID B cells including those expressing IgD(+) CD27(+), in analogy to cord blood and hyper-IgM syndrome B cells, may be responsible for their failure to differentiate into plasma cells and to produce high-affinity antibodies of different isotypes.
...
PMID:Absence of memory B cells in patients with common variable immunodeficiency. 1198 83
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>